Top Ten Topics in Clinical Cardiology

1. • Incorporate the latest developments within interventional cardiology and assess their effects on improving interventional outcomes and overall patient care.
2. • Evaluate and differentiate between the newest innovative approaches in the treatment of heart failure to optimize patient management and care.
3. • Identify the recent transcatheter mitral valve therapies with special focus on MitraClip and TAVR procedures, aiming to enhance patient outcomes.
4. • Analyze the role of noninvasive testing in diagnosing coronary artery disease (CAD) and accurately provide prognostic information to guide patient treatment and care.
5. • Apply evidence-based strategies for the prevention and management of hypertension to optimize blood pressure control and reduce cardiovascular risks in patients.
6. • Assess the latest advancements in cardiac imaging technologies and their role in aiding accurate diagnoses and treatment planning for various cardiovascular conditions.

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Annapoorna S. Kini, MD, MRCP, FACC
Director, Cardiac Catheterization Laboratory/Interventional Cardiology Fellowship Program & Structural Heart Program
Director of Process Optimization System Catheterization Laboratories, Mount Sinai Health System

Course Director, Faculty

Nothing to disclose

Samin K. Sharma, MD, MSCAI, FACC
Director, Cardiovascular Clinical Institute/Senior Vice President, Operations and Quality, Mount Sinai Fuster Heart Hospital
Director, Interventional Cardiology, Mount Sinai Health System/ President Mount Sinai Heart Network

Course Director, Faculty

Nothing to disclose

Deepak L Bhatt, MD, MPH, MBA, FACC, FAHA,FESC,MSCAI
Director of Mount Sinai Fuster Heart Hospital
Dr. Valentin Fuster Prof of Cardiovascular Medicine
Icahn School of Medicine at Mount Sinai, NY

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol Myers Squibb|Stocks or stock options, excluding diversified mutual funds-Bristol Myers Squibb|Grant or research support-89 Bio|Grant or research support-Amgen|Grant or research support-Astrazeneca|Grant or research support-Bayer|Grant or research support-Boehringer Ingelheim Boehringer Ingelheim|Grant or research support-Boston Scientific|Grant or research support-Eli Lilly|Grant or research support-Janssen|Grant or research support-Novartis|Grant or research support-Novo Nordisk|Grant or research support-Pfizer Pharmaceuticals|Grant or research support-Sanofi Genzyme|Grant or research support-Afimmune|Grant or research support-Amarin|Grant or research support-Amgen|Grant or research support-Chiesi|Grant or research support-Faraday|Grant or research support-Fractyl|Grant or research support-Idorsia|Grant or research support-Lexicon|Grant or research support-Medtronic|Grant or research support-PhaseBio|Grant or research support-PLx Phama

Cathleen Biga, MSN, RN, FACC
Vice President American College of Cardiology
President/CEO Cardiovascular Management of Illinois
Woodridge, IL

Faculty

Nothing to disclose

Srinivas Dukkipati, MD
Professor of Medicine, Cardiology
Director, EP Lab – Mount Sinai Hospital

Faculty

Stocks or stock options, excluding diversified mutual funds-Boston Scientific

Valentin Fuster, MD, PhD, MACC
Physician In Chief, Mount Sinai Hospital/President, Mount Sinai Fuster Heart Hospital
Prof. The Richard Gorlin, MD/Heart Research Foundation at The Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai

Faculty

Nothing to disclose

David Maron, MD
C.F. Rehnborg Professor of Medicine
Chief, Stanford Prevention Research Center
Stanford Univ School of Medicine, Stanford, CA

Faculty

Consulting Fee-Regeneron Regeneron|Consulting Fee-Scilex

Roxana Mehran, MD, FACC, FAHA, MSCAI
Director of Interventional Cardiovascular Research and Clinical Trials
Professor of Medicine, Cardiology and of Population Health Science and Policy

Faculty

Grant or research support-Abbott, Abiomed, Alleviant Medical, Amgen, AM-Pharma, Arena, AstraZeneca, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi, Concept Medical, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Humacyte, Idorsia Pharmaceuticals, Janssen, Magenta, Mediasphere, Medtelligence, Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll; |Other: Personal Fees-AstraZeneca, Ionis Pharmaceuticals, J-CalC, Novartis, Novo Nordisk, Vectura, WebMD; Equity <1% in Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse); AMA (Scientific Advisory Board, JAMA Cardiology Associate Editor), ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member); Faculty CRF (no fee).|Consulting Fee-Medtronic|Consulting Fee-Novartis|Independent Contractor (included contracted research)-Abiomed|Independent Contractor (included contracted research)-Astrazeneca|Independent Contractor (included contracted research)-Bayer|Independent Contractor (included contracted research)-Boston Scientific|Independent Contractor (included contracted research)-Bristol Myers Squibb|Independent Contractor (included contracted research)-Medtronic|Independent Contractor (included contracted research)-Novartis|Independent Contractor (included contracted research)-Philips

Jagat Narula, MD, PhD
,

Faculty

Nothing to disclose

Sean Pinney, MD
Philip J. and Harriet L. Goodhart Chief of Cardiology
Mount Sinai Morningside
Wyckoff, NJ

Faculty

Advisor-Impulse Dynamics, Cordio, Nuwellis|Consulting Fee-Abbott, Ancora, Medtronic

David L. Reich, MD
President, The Mount Sinai Hospital and Mount Sinai Queens
Horace W. Goldsmith Professor, Anesthesiology Perioperative and Pain Medicine

Faculty

Nothing to disclose

Gregg W Stone, MD, FACC, MSCAI
Director of Academic Affairs for the Mount Sinai Heart Health System
Professor of Medicine (Cardiology) and Population Health Sciences and Policy
New York City, NY

Faculty

Honoraria-Medtronic, Pulnovo, Abiomed, Amgen, Boehringer Ingelheim (Relationship has ended)|Consulting Fee-Abbott, Daiichi Sankyo, CorFlow, Cardiomech, Ablative Solutions, Robocath, Miracor, Vectorious, Apollo Therapeutics (Relationship has ended)|Consulting Fee-Valfix, TherOx, HeartFlow, Neovasc, Ancora, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical, Millennia Biopharma, Oxitope, Cardiac Success, HighLife|Stocks or stock options, excluding diversified mutual funds-Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter|Grant or research support-Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo, V-wave

Friday, October 6, 2023